中华皮肤科杂志 ›› 2018, Vol. 51 ›› Issue (10): 766-768.doi: 10.3760/cma.j.issn.0412-4030.2018.10.019
郑瑀心1,李欣欣2,郑敏2
收稿日期:2017-10-12
修回日期:2017-12-12
出版日期:2018-10-15
发布日期:2018-10-03
通讯作者:
郑敏
E-mail:minz@zju.edu.cn
Zheng Yuxin, Li Xinxin, Zheng Min
Received:2017-10-12
Revised:2017-12-12
Online:2018-10-15
Published:2018-10-03
Contact:
Zheng Min
E-mail:minz@zju.edu.cn
摘要： 银屑病是一种慢性炎症性疾病，除典型皮损外，还可合并关节炎、心血管疾病、代谢性疾病等，对患者的生理、心理健康均产生深远影响［1］。治疗目的在于控制病情，延缓发展，减轻症状，延长缓解期，尽量减少治疗不良反应，提高患者生活质量［2］。大部分银屑病患者病情属轻中度，应以外用药物治疗为主。但至少有三分之一的银屑病患者，因外用药方法繁琐，用药后影响外观，担心不良反应，或是对外用药是否有效心存疑虑等，不使用或不能正确使用外用药［3］。对于银屑病患者而言，能够坚持正确使用，且疗效确切的外用药就是最好的外用药［4］。世界卫生组织指出，在良好的医患沟通情况下，患者遵照并履行医师开具的处方的程度，即依从性，是有效治疗慢性疾病的关键因素和一大挑战。不良的依从性可能导致医生低估当前的治疗效果而调整治疗方案或用药剂量……
中图分类号:
郑瑀心 李欣欣 郑敏. 通过分析银屑病患者心理特征提高使用外用药的依从性[J]. 中华皮肤科杂志, 2018, 51(10): 766-768.
Zheng Yuxin, Li Xinxin, Zheng Min. Improving adherence to topical treatment of psoriasis by analyzing psychological features of patients[J]. Chinese Journal of Dermatology, 2018, 51(10): 766-768.
| ［1］ | Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: Epidemiology［J］. J Am Acad Dermatol, 2017,76（3）:377⁃390. doi: 10.1016/j.jaad.2016.07.064.<br /> |
| ［2］ | 中华医学会皮肤性病分会银屑病学组. 中国银屑病治疗专家共识（2014版）［J］. 中华皮肤科杂志, 2014,47（3）:213⁃215. doi: 10.3760/cma.j.issn.0412⁃4030.2014.03.017.<br /> |
| ［3］ | Zschocke I, Mrowietz U, Karakasili E, et al. Non⁃adherence and measures to improve adherence in the topical treatment of psoriasis［J］. J Eur Acad Dermatol Venereol, 2014,28 Suppl 2:4⁃9. doi: 10.1111/jdv.12445.<br /> |
| ［4］ | Torsekar R, Gautam MM. Topical therapies in psoriasis［J］. Indian Dermatol Online J, 2017,8（4）:235⁃245. doi: 10.4103/2229⁃5178.209622.<br /> |
| ［5］ | Bewley A, Burrage DM, Ersser SJ, et al. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two⁃stage qualitative and quantitative study［J］. J Eur Acad Dermatol Venereol, 2014,28（6）:763⁃770. doi: 10.1111/jdv.12174.<br /> |
| ［6］ | Gonzalez JM, Johnson FR, McAteer H, et al. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete⁃choice experiment［J］. Br J Dermatol, 2017,176（3）:777⁃785. doi: 10.1111/ bjd.14798.<br /> |
| ［7］ | Choi JW, Kim BR, Youn SW. Adherence to topical therapies for the treatment of psoriasis: surveys of physicians and patients［J］. Ann Dermatol, 2017,29（5）:559⁃564. doi: 10.5021/ad.2017.29.5. 559.<br /> |
| ［8］ | Plost GR, Stoff BK. Medication nonadherence in dermatology: divergent ethical implications for patient care［J］. J Am Acad Dermatol, 2017,77（4）:787⁃789. doi: 10.1016/j.jaad.2017.02.020.<br /> |
| ［9］ | Daudén E, Bewley A, Lambert J, et al. Expert recommendations: the use of the fixed combination calcipotriol and betame⁃thasone dipropionate gel for the topical treatment of psoriasis［J］. J Eur Acad Dermatol Venereol, 2014,28 Suppl 2:22⁃32. doi: 10.1111/jdv.12443.<br /> |
| ［10］ | Perrone V, Sangiorgi D, Buda S, et al. Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units［J］. Clinicoecon Outcomes Res, 2017,9:181⁃188. doi: 10.2147/CEOR.S126975.<br /> |
| ［11］ | Eliasson L, Bewley AP, Mughal F, et al. Evaluation of psoriasis patients′ attitudes toward benefit⁃risk and therapeutic trade⁃offs in their choice of treatments［J］. Patient Prefer Adherence, 2017,11:353⁃362. doi: 10.2147/PPA.S121838.<br /> |
| ［12］ | Reich K, Mrowietz U, Karakasili E, et al. Development of an adherence⁃enhancing intervention in topical treatment termed the topical treatment optimization program （TTOP）［J］. Arch Dermatol Res, 2014,306（7）:667⁃676. doi: 10.1007/s00403⁃014⁃1475⁃5.<br /> |
| ［13］ | Svendsen MT, Andersen F, Hansen J, et al. Medical adherence to topical corticosteroid preparations prescribed for psoriasis: a systematic review［J］. J Dermatolog Treat, 2017,28（1）:32⁃39. doi: 10.1080/09546634.2016.1178375.<br /> |
| ［14］ | Eissing L, Radtke MA, Zander N, et al. Barriers to guideline⁃compliant psoriasis care: analyses and concepts［J］. J Eur Acad Dermatol Venereol, 2016,30（4）:569⁃575. doi: 10.1111/jdv.13452.<br /> |
| ［15］ | Thorneloe RJ, Bundy C, Griffiths CE, et al. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis［J］. Br J Dermatol, 2017,176（3）:667⁃676. doi: 10.1111/bjd.15086.<br /> |
| ［16］ | Zschocke I, Ortland C, Reich K. Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics: the importance of physician⁃patient interaction and communication［J］. J Eur Acad Dermatol Venereol, 2017,31（6）:1014⁃1020. doi: 10.1111/jdv.14178.<br /> |
| ［17］ | Teixeira A, Teixeira M, Almeida V, et al. Methodologies for medication adherence evaluation: focus on psoriasis topical treatment［J］. J Dermatol Sci, 2016,82（2）:63⁃68. doi: 10.1016/j.jdermsci.2016.02.008.<br /> |
| ［18］ | Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta⁃analysis［J］. Med Care, 2009,47（8）:826⁃834. doi: 10.1097/MLR.0b013e31819a5acc.<br /> |
| ［19］ | Schaarschmidt ML, Umar N, Schmieder A, et al. Patient preferences for psoriasis treatments: impact of treatment experi⁃ence［J］. J Eur Acad Dermatol Venereol, 2013,27（2）:187⁃198. doi: 10.1111/j.1468⁃3083.2011.04440.x.<br /> |
| ［20］ | Stein GLF. Topical therapies for psoriasis: improving management strategies and patient adherence［J］. Semin Cutan Med Surg, 2016,35（2 Suppl 2）:S36⁃45. doi: 10.12788/j.sder.2016. 006.<br /> |
| ［21］ | Tan J, Linos E, Sendelweck MA, et al. Shared decision making and patient decision aids in dermatology［J］. Br J Dermatol, 2016,175（5）:1045⁃1048. doi: 10.1111/bjd.14803.<br /> |
| ［22］ | Kontochristopoulos G, Kouris A, Chantzaras A, et al. Improvement of health⁃related quality of life and adherence to treatment with calcipotriol⁃betamethasone dipropionate gel in patients with psoriasis vulgaris［J］. An Bras Dermatol, 2016,91（2）:160⁃166. doi: 10.1590/abd1806⁃4841.20164476.<br /> |
| ［23］ | Ahn CS, Culp L, Huang WW, et al. Adherence in dermatology［J］. J Dermatolog Treat, 2017,28（2）:94⁃103. doi: 10.1080/09546634. 2016.1181256.<br /> |
| ［24］ | Schinkel S, Schouten BC, Street RL, et al. Enhancing health communication outcomes among ethnic minority patients: the effects of the match between participation preferences and perceptions and doctor⁃patient concordance［J］. J Health Commun, 2016,21（12）:1251⁃1259. doi: 10.1080/10810730.2016.1240269.<br /> |
| ［25］ | Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple［J］. Med Gen Med, 2005,7（1）:4.<br /> |
| ［26］ | Alinia H, Moradi TS, Smith JA, et al. Long⁃term adherence to topical psoriasis treatment can be abysmal: a 1⁃year random⁃ized intervention study using objective electronic adherence monitoring［J］. Br J Dermatol, 2017,176（3）:759⁃764. doi: 10.1111/bjd.15085.<br /> |
| [1] | 王霞 杨阁 李凌 魏荣芳 熊春萍. 一汉族念珠状发家系调查和Ⅱ型毛发角蛋白基因突变分析[J]. 中华皮肤科杂志, 2019, 52(8): 561-564. |
| [2] | 冯霞 叶欣 舒慧玲 余蓓 黎昌强. 患者健康问卷抑郁量表9在痤疮患者中的信度和效度检验[J]. 中华皮肤科杂志, 2019, 52(7): 461-466. |
| [3] | 谢波 王永芳 宋莎莎 吴建兵 李新宇. 和厚朴酚对大鼠脊髓背根神经元细胞瞬时受体电位通道活化和小鼠模型瘙痒的影响[J]. 中华皮肤科杂志, 2019, 52(7): 455-460. |
| [4] | 李遇梅 张怡萱 刘莉萍. 诱导性多功能干细胞在皮肤科研究与应用的进展[J]. 中华皮肤科杂志, 2019, 52(7): 445-449. |
| [5] | 雷杰豪 樊奇敏 陈荣 许爱娥. 白癜风患者窄谱中波紫外线治疗效果与光疗反应的关系及相关因素分析[J]. 中华皮肤科杂志, 2019, 52(4): 259-262. |
| [6] | 陈玉迪 耿鹏 赵嘉惠 涂平 赵作涛. 慢性自发性荨麻疹：免疫学发病机制及抗IgE治疗作用机制与疗效评估[J]. 中华皮肤科杂志, 0, (): 0-0. |
| [7] | 刘洋 徐宇 张芙蓉 谭灿 杨国玲. 犬小孢子菌PQ-LRP蛋白的定位研究[J]. 中华皮肤科杂志, 2019, 52(3): 189-192. |
| [8] | 智慧林 夏修蛟 刘泽虎 沈宏 许爱娥. 杭州某医院2015—2017年头癣病原菌分析[J]. 中华皮肤科杂志, 2019, 52(3): 193-195. |
| [9] | 熊娟娟 毕健平 孙德祥 李念 鲁巧云. 甲真菌病和甲银屑病的皮肤镜特征分析[J]. 中华皮肤科杂志, 2019, 52(2): 106-110. |
| [10] | 鲁静浩 周行 刘超凡 朱鹭冰 李明. 皮肌炎皮疹与间质性肺病相关性的研究进展[J]. 中华皮肤科杂志, 2018, 51(10): 779-781. |
| [11] | 张洋洋 李冰 王刚. 银屑病皮损CD8αα+ T细胞表型鉴定[J]. 中华皮肤科杂志, 2018, 51(10): 729-732. |
| [12] | 张丽丹 林玲 曾菁莘 刘炜钰 罗权. 黄金微针射频治疗面部痤疮瘢痕的疗效评估[J]. 中华皮肤科杂志, 2018, 51(9): 672-675. |
| [13] | 司鹤南 李珊山 温泉 张红 于艳. 持久性隆起性红斑伴眼部损害一例[J]. 中华皮肤科杂志, 2018, 51(8): 625-626. |
| [14] | 周文娇 任杰 韩珑 刘欣欣 汤坤龙 罗素菊. 白细胞介素22对人表皮角质形成细胞CC趋化因子配体27表达的影响[J]. 中华皮肤科杂志, 2018, 51(8): 592-594. |
| [15] | 陈玲境 韩睿 程浩. 原发肾上腺NK/T细胞淋巴瘤皮肤侵犯一例[J]. 中华皮肤科杂志, 2018, 51(7): 544-545. |
|
